Menu
/REGISTER
Montecito
Nixon Peabody
Pac Premier
Loading...
You are here:  Home  >  'arthritis'
Latest

Judge upholds Amgen’s Enbrel patents

By   /  Wednesday, July 1st, 2020  /  Biotech, Earnings, East Ventura County, Latest news, Technology, Tri-County Public Companies  /  Comments Off on Judge upholds Amgen’s Enbrel patents

This article is only available to Business Times subscribers Subscribers: LOG IN or REGISTER for complete digital access. Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists. Check the STATUS of your Subscription Account.

Read More →
Latest

Amgen gets approval for arthritis drug biosimilar

By   /  Friday, December 6th, 2019  /  Biotech, Central Coast Health Watch, East Ventura County, Latest news  /  Comments Off on Amgen gets approval for arthritis drug biosimilar

This article is only available to Business Times subscribers Subscribers: LOG IN or REGISTER for complete digital access. Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists. Check the STATUS of your Subscription Account.

Read More →
Latest

Higher product sales help Amgen beat analyst expectations for first quarter

By   /  Tuesday, April 24th, 2018  /  Central Coast Health Watch, Earnings, Latest news, Technology, Tri-County Public Companies  /  Comments Off on Higher product sales help Amgen beat analyst expectations for first quarter

This article is only available to Business Times subscribers Subscribers: LOG IN or REGISTER for complete digital access. Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists. Check the STATUS of your Subscription Account.

Read More →
Latest

Santa Barbara doctor writes memoir of Vietnam War

By   /  Friday, June 2nd, 2017  /  Central Coast Health Watch, Features, Latest news  /  Comments Off on Santa Barbara doctor writes memoir of Vietnam War

This article is only available to Business Times subscribers Subscribers: LOG IN or REGISTER for complete digital access. Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists. Check the STATUS of your Subscription Account.

Read More →
Latest

FDA approves Amgen biosimilar of AbbVie’s Humira

By   /  Friday, September 23rd, 2016  /  Central Coast Health Watch, East Ventura County, Latest news  /  Comments Off on FDA approves Amgen biosimilar of AbbVie’s Humira

The Food and Drug Administration approved Amgen’s Humira biosimilar Sept. 23. Amjevita, formerly known as ABP 501 and made by Thousand Oaks-biotech giant Amgen, replicates the effects of Humira, which is approved to treat nine conditions including rheumatoid arthritis, skin disorders and colon inflammation. Humira, made by Chicago-based competitor AbbVie, typically costs $20,000 per year Read More →

Read More →